Equity Analysis /
United States of America

US : Mirum Pharmaceuticals, Inc. - MIRM | New Vivet Deal Expands Portfolio Into AAV Gene Therapy

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    12 April 2021
    Published by